 | Up a level |
Califf, RM; Boolell, M; Haffner, SM; Bethel, MA; McMurray, J; Duggal, A; Holman, RR; NAVIGATOR, ; Study Group, (2008). Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. American Heart Journal, 156(4), (2008), pp. 623-632. St. Louis, Mo.: Elsevier 10.1016/j.ahj.2008.05.017
